Family Medicine Doctors in Avenal, CA Accepting Medicare

3 Family Medicine doctors found. Showing 1 - 3

Kelvis Gonzalez Gallardo, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 148 E Kings St, Avenal, CA 93204 Phone: 559-386-9000    Fax: 559-386-9090

Dr. Steven Jeffrey Douglass, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Kings Way, Chief Medical Officer, Avenal, CA 93204 Phone: 559-386-0587

Dr. Jasmine Rarang Biol, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Kings Way, Medical Department Avenal State Prison, Avenal, CA 93204 Phone: 559-386-0587

News Archive

WHO applauds South African parliament for passing sugary drinks tax bill

The South African Parliament has taken a brave and powerful step towards promoting the health of the country's citizens and reducing diet-related noncommunicable diseases (NCDs), such as diabetes, by passing a bill yesterday to implement a tax on sugar-sweetened beverages, according to Dr Rufaro Chatora, WHO's Representative to South Africa.

Medidata first quarter revenues increase 24% to $50.4 million

Medidata Solutions, a leading global provider of cloud-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the first quarter of 2012, and provided detailed financial guidance for the second quarter and full year 2012.

Blocking Slit2 protein prevents blood vessel development that causes vasoproliferative ocular diseases

Vasoproliferative ocular diseases are responsible for sight loss in millions of people in the industrialised countries. Many patients do not currently respond to the treatment offered, which targets a specific factor, VEGF. A team of Inserm researchers at the Vision Institute (Inserm/CNRS/Pierre and Marie Curie University), in association with a team from the Yale Cardiovascular Research Center, have demonstrated in an animal model that blocking another protein, Slit2, prevents the pathological blood vessel development that causes these diseases.

Capario releases Portal 3.6 revenue cycle management solution

Capario, a leading provider of revenue cycle management solutions that connect healthcare payers and providers nationwide, today announced it has launched Portal 3.6, which includes the most significant advances to its exclusive online portal application to date.

Avila's AVL-292 demonstrates disease-modifying effects in prophylactic, therapeutic models of rheumatoid arthritis

Avila Therapeutics™, Inc., a biotechnology company developing targeted covalent drugs that treat diseases through protein silencing, today announced results of preclinical studies demonstrating that its clinical candidate, AVL-292, potently inhibits B cell receptor signaling, and demonstrates efficacy in a rodent model of rheumatoid arthritis. These new data were presented Saturday, June 26, 2010 at the Federation of Clinical Immunology Societies (FOCIS) 2010 annual meeting in Boston, MA.

Read more Medical News

› Verified 3 days ago